Rising prevalence of benign prostatic hyperplasia is expected to drive growth of the prostatic artery embolization market over the forecast period.
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |